163 related articles for article (PubMed ID: 31276346)
1. Epigenetics in non-small cell lung carcinomas.
Peralta-Arrieta I; Armas-López L; Zúñiga J; Ávila-Moreno F
Salud Publica Mex; 2019; 61(3):318-328. PubMed ID: 31276346
[TBL] [Abstract][Full Text] [Related]
2. LINE-1 hypomethylation is associated to specific clinico-pathological features in Stage I non-small cell lung cancer.
Imperatori A; Sahnane N; Rotolo N; Franzi F; Nardecchia E; Libera L; Romualdi C; Cattoni M; Sessa F; Dominioni L; Furlan D
Lung Cancer; 2017 Jun; 108():83-89. PubMed ID: 28625654
[TBL] [Abstract][Full Text] [Related]
3. Epigenetics in lung cancer diagnosis and therapy.
Mehta A; Dobersch S; Romero-Olmedo AJ; Barreto G
Cancer Metastasis Rev; 2015 Jun; 34(2):229-41. PubMed ID: 25939322
[TBL] [Abstract][Full Text] [Related]
4. Genomewide DNA methylation analysis identifies novel methylated genes in non-small-cell lung carcinomas.
Carvalho RH; Hou J; Haberle V; Aerts J; Grosveld F; Lenhard B; Philipsen S
J Thorac Oncol; 2013 May; 8(5):562-73. PubMed ID: 23524404
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy.
Ricciuti B; Mencaroni C; Paglialunga L; Paciullo F; Crinò L; Chiari R; Metro G
Med Oncol; 2016 Feb; 33(2):18. PubMed ID: 26786153
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.
Di Paolo A; Del Re M; Petrini I; Altavilla G; Danesi R
Epigenomics; 2016 Aug; 8(8):1151-67. PubMed ID: 27479016
[TBL] [Abstract][Full Text] [Related]
7. A Systematic Review of Progress toward Unlocking the Power of Epigenetics in NSCLC: Latest Updates and Perspectives.
Sulewska A; Pilz L; Manegold C; Ramlau R; Charkiewicz R; Niklinski J
Cells; 2023 Mar; 12(6):. PubMed ID: 36980246
[TBL] [Abstract][Full Text] [Related]
8. G9a regulates tumorigenicity and stemness through genome-wide DNA methylation reprogramming in non-small cell lung cancer.
Pangeni RP; Yang L; Zhang K; Wang J; Li W; Guo C; Yun X; Sun T; Wang J; Raz DJ
Clin Epigenetics; 2020 Jun; 12(1):88. PubMed ID: 32552834
[TBL] [Abstract][Full Text] [Related]
9. Independent Validation of Early-Stage Non-Small Cell Lung Cancer Prognostic Scores Incorporating Epigenetic and Transcriptional Biomarkers With Gene-Gene Interactions and Main Effects.
Zhang R; Chen C; Dong X; Shen S; Lai L; He J; You D; Lin L; Zhu Y; Huang H; Chen J; Wei L; Chen X; Li Y; Guo Y; Duan W; Liu L; Su L; Shafer A; Fleischer T; Moksnes Bjaanæs M; Karlsson A; Planck M; Wang R; Staaf J; Helland Å; Esteller M; Wei Y; Chen F; Christiani DC
Chest; 2020 Aug; 158(2):808-819. PubMed ID: 32113923
[TBL] [Abstract][Full Text] [Related]
10. Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.
Juergens RA; Wrangle J; Vendetti FP; Murphy SC; Zhao M; Coleman B; Sebree R; Rodgers K; Hooker CM; Franco N; Lee B; Tsai S; Delgado IE; Rudek MA; Belinsky SA; Herman JG; Baylin SB; Brock MV; Rudin CM
Cancer Discov; 2011 Dec; 1(7):598-607. PubMed ID: 22586682
[TBL] [Abstract][Full Text] [Related]
11. CARM1 promotes non-small cell lung cancer progression through upregulating CCNE2 expression.
Wu D; He J; Zhang W; Wang K; Jin S; Li J; Gao W
Aging (Albany NY); 2020 Jun; 12(11):10578-10593. PubMed ID: 32487779
[TBL] [Abstract][Full Text] [Related]
12. SFRP1 is a possible candidate for epigenetic therapy in non-small cell lung cancer.
Taguchi YH; Iwadate M; Umeyama H
BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):28. PubMed ID: 27534621
[TBL] [Abstract][Full Text] [Related]
13. Aberrant methylation in non-small cell lung cancer.
Suzuki M; Yoshino I
Surg Today; 2010 Jul; 40(7):602-7. PubMed ID: 20582509
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic therapy approaches in non-small cell lung cancer: Update and perspectives.
Schiffmann I; Greve G; Jung M; Lübbert M
Epigenetics; 2016 Dec; 11(12):858-870. PubMed ID: 27846368
[TBL] [Abstract][Full Text] [Related]
15. DNA methylome analysis identifies BMI-related epigenetic changes associated with non-small cell lung cancer susceptibility.
Li G; Meng H; Bai Y; Wei W; Feng Y; Li M; Li H; He M; Zhang X; Wei S; Li Y; Guo H
Cancer Med; 2021 Jun; 10(11):3770-3781. PubMed ID: 33939316
[TBL] [Abstract][Full Text] [Related]
16. Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer.
Li L; Zhu T; Gao YF; Zheng W; Wang CJ; Xiao L; Huang MS; Yin JY; Zhou HH; Liu ZQ
Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27258253
[TBL] [Abstract][Full Text] [Related]
17. [Research progress on epigenetics of lung cancer].
Wang Y; Jin Y
Wei Sheng Yan Jiu; 2007 Jan; 36(1):109-11. PubMed ID: 17424862
[TBL] [Abstract][Full Text] [Related]
18. Estrogen receptor expression and gene promoter methylation in non-small cell lung cancer - a short report.
Tekpli X; Skaug V; Bæra R; Phillips DH; Haugen A; Mollerup S
Cell Oncol (Dordr); 2016 Dec; 39(6):583-589. PubMed ID: 27572263
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic Suppression of the T-box Subfamily 2 (
Nehme E; Rahal Z; Sinjab A; Khalil A; Chami H; Nemer G; Kadara H
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30866410
[TBL] [Abstract][Full Text] [Related]
20. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
[Next] [New Search]
